James P. Naude
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response to concerns with the statistical analysis in "Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study".
Journal: International journal of obesity (2005)
Published: March 02, 2026
Retraction Note: Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study.
Journal: International journal of obesity (2005)
Published: December 19, 2025
Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
Journal: medRxiv : the preprint server for health sciences
Published: February 26, 2024
Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study.
Journal: International journal of obesity (2005)
Published: July 20, 2023
Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
Journal: Neurobiology of aging
Published: July 13, 2023
Plasma β-Amyloid in Mild Behavioural Impairment - Neuropsychiatric Symptoms on the Alzheimer's Continuum.
Journal: Journal of geriatric psychiatry and neurology
Published: May 26, 2021
Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.
Journal: Journal of Alzheimer's disease : JAD
Published: June 30, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026